Efficacy and safety of belimumab in paediatric and adult patients with systemic lupus erythematosus: an across-study comparison

• Hermine I Brunner,
• Nicolino Ruperto,
• Clarissa A Pilkington,
• Damon L Bass,
• Mohamed Okily,
• Holly Quasny,
• Fengchun Zhang,
• Syuji Takei,
• Carlos Abud-Mendoza,
• Diego O Viola,
• Beulah N Ji,
• David A Roth,
• Masaaki Mori,
• Sandra Navarra,
• Reema Syed,
• Gina Eriksson,
• Anne E Hammer

Affiliations

Hermine I Brunner

Division of Rheumatology, Cincinnati Children`s Hospital Medical Center, Cincinnati, Ohio, USA

Nicolino Ruperto

IRCCS Istitutu Giannina Gaslini, Clinica Pediatrica e Reumatologia, PRINTO, Genova, Italy

Clarissa A Pilkington

Great Ormond Street Hospital for Children, London, UK

Damon L Bass

GlaxoSmithKline, Collegeville, Pennsylvania, USA

Mohamed Okily

GlaxoSmithKline, Brentford, UK

Holly Quasny

GlaxoSmithKline, Research Triangle Park, North Carolina, USA

Fengchun Zhang

Department of Rheumatology, Peking Union Medical College Hospital, Dongcheng-qu, Beijing, China

Syuji Takei

Pediatrics and Developmental Medicine, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan

Carlos Abud-Mendoza

Unidad Regional de Reumatologia y Osteoporosis, Hospital Central and Facultad de Medicina, Universidad Autonoma de San Luis Potosi, San Luis Potosi, Mexico

Diego O Viola

Reumatologia, Instituto CAICI, Rosario, Argentina

Beulah N Ji

GlaxoSmithKline, Brentford, UK

David A Roth

GlaxoSmithKline, Collegeville, Pennsylvania, USA

Masaaki Mori

Department of Lifetime Clinical Immunology, Tokyo Medical and Dental University, Bunkyo-ku, Japan

Sandra Navarra

University of Santo Tomas, Manila, Philippines

Reema Syed

Washington University in St Louis School of Medicine, St Louis, Missouri, USA

Gina Eriksson

GlaxoSmithKline, Collegeville, Pennsylvania, USA

Anne E Hammer

GlaxoSmithKline, Collegeville, Pennsylvania, USA